Show Search Form
human indexable | ||||||||
---|---|---|---|---|---|---|---|---|
published | ||||||||
registered interest | ||||||||
answer date | ||||||||
date | ||||||||
date tabled | ||||||||
ddp created | ||||||||
answering body |
|
|||||||
question status | Tabled | |||||||
answering dept id | 17 | |||||||
answering dept short name | Health and Social Care | |||||||
answering dept sort name | Health and Social Care | |||||||
ddp modified |
|
|||||||
hansard heading | Alzheimer's Disease: Screening | |||||||
house id | 1 | |||||||
identifier | 16636 | |||||||
legislature |
|
|||||||
parliament number | 58 | |||||||
question first answered |
|
|||||||
question text | To ask the Secretary of State for Health and Social Care, whether her Department is taking steps to expand testing for Alzheimer's to enable people to benefit at an early stage from new treatments (a) lecanemab and (b) other new treatments. | |||||||
session |
|
|||||||
session number | 4 | |||||||
tabling member constituency | Chipping Barnet | |||||||
tabling member printed |
|
|||||||
title | House of Commons Tabled Parliamentary Question 2023/24 16636 | |||||||
type |
|
|||||||
uin | 16636 | |||||||
version | 1 | |||||||
written parliamentary question type | NamedDay | |||||||
answer | answer | |||||||
creator |
|
|||||||
publisher | 25259 | |||||||
tabling member |
|